148 related articles for article (PubMed ID: 32637030)
1. RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit.
Chae HD; Dutta R; Tiu B; Hoff FW; Accordi B; Serafin V; Youn M; Huang M; Sumarsono N; Davis KL; Lacayo NJ; Pigazzi M; Horton TM; Kornblau SM; Sakamoto KM
Oncotarget; 2020 Jun; 11(25):2387-2403. PubMed ID: 32637030
[TBL] [Abstract][Full Text] [Related]
2. RSK Inhibition Induces Apoptosis by Downregulating Protein Synthesis in a Variety of Acute Myeloid Leukemia Cell Lines.
Katayama K; Nishihata A
Biol Pharm Bull; 2021 Dec; 44(12):1843-1850. PubMed ID: 34602526
[TBL] [Abstract][Full Text] [Related]
3. Overcoming resistance to Sonic Hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma.
Pambid MR; Berns R; Adomat HH; Hu K; Triscott J; Maurer N; Zisman N; Ramaswamy V; Hawkins CE; Taylor MD; Dunham C; Guns E; Dunn SE
Pediatr Blood Cancer; 2014 Jan; 61(1):107-15. PubMed ID: 23940083
[TBL] [Abstract][Full Text] [Related]
4. The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK- and p53-independent accumulation of p21WAF1/CIP1.
Neise D; Sohn D; Stefanski A; Goto H; Inagaki M; Wesselborg S; Budach W; Stühler K; Jänicke RU
Cell Death Dis; 2013 Oct; 4(10):e859. PubMed ID: 24136223
[TBL] [Abstract][Full Text] [Related]
5. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
[TBL] [Abstract][Full Text] [Related]
6. BI-D1870 Induces Mitotic Dysfunction and Apoptosis in Neuroblastoma by Regulating the PI3K-Akt-mTORC1 Signal Axis.
Jin L; Mi T; Wu X; Wang Z; Zhang Z; Liu J; Wang Z; Wang J; Li M; Ren C; Guo P; He D
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046682
[No Abstract] [Full Text] [Related]
7. Inhibition of p90 ribosomal S6 kinase potentiates cisplatin activity in A549 human lung adenocarcinoma cells.
Abdulrahman N; Siveen KS; Joseph JM; Osman A; Yalcin HC; Hasan A; Uddin S; Mraiche F
J Pharm Pharmacol; 2020 Nov; 72(11):1536-1545. PubMed ID: 32667058
[TBL] [Abstract][Full Text] [Related]
8. A combination of SILAC and nucleotide acyl phosphate labelling reveals unexpected targets of the Rsk inhibitor BI-D1870.
Edgar AJ; Trost M; Watts C; Zaru R
Biosci Rep; 2014 Feb; 34(1):. PubMed ID: 27919044
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of BI-D1870 on human oral squamous cell carcinoma.
Chiu CF; Bai LY; Kapuriya N; Peng SY; Wu CY; Sargeant AM; Chen MY; Weng JR
Cancer Chemother Pharmacol; 2014 Feb; 73(2):237-47. PubMed ID: 24241211
[TBL] [Abstract][Full Text] [Related]
10. Bub1 is activated by the protein kinase p90(Rsk) during Xenopus oocyte maturation.
Schwab MS; Roberts BT; Gross SD; Tunquist BJ; Taieb FE; Lewellyn AL; Maller JL
Curr Biol; 2001 Feb; 11(3):141-50. PubMed ID: 11231148
[TBL] [Abstract][Full Text] [Related]
11. Divergent off-target effects of RSK N-terminal and C-terminal kinase inhibitors in cardiac myocytes.
Stathopoulou K; Schobesberger S; Bork NI; Sprenger JU; Perera RK; Sotoud H; Geertz B; David JP; Christ T; Nikolaev VO; Cuello F
Cell Signal; 2019 Nov; 63():109362. PubMed ID: 31344438
[TBL] [Abstract][Full Text] [Related]
12. Mad2-independent spindle assembly checkpoint activation and controlled metaphase-anaphase transition in Drosophila S2 cells.
Orr B; Bousbaa H; Sunkel CE
Mol Biol Cell; 2007 Mar; 18(3):850-63. PubMed ID: 17182852
[TBL] [Abstract][Full Text] [Related]
13. The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice.
Takada I; Yogiashi Y; Makishima M
Immunobiology; 2016 Feb; 221(2):188-92. PubMed ID: 26386981
[TBL] [Abstract][Full Text] [Related]
14. Induction of C-anaphase and diplochromosome through dysregulation of spindle assembly checkpoint by sodium arsenite in human fibroblasts.
Yih LH; Lee TC
Cancer Res; 2003 Oct; 63(20):6680-8. PubMed ID: 14583462
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory factors associated with anaphase-promoting complex/cylosome in mitotic checkpoint.
Braunstein I; Miniowitz S; Moshe Y; Hershko A
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):4870-5. PubMed ID: 17360335
[TBL] [Abstract][Full Text] [Related]
16. Identification of an overlapping binding domain on Cdc20 for Mad2 and anaphase-promoting complex: model for spindle checkpoint regulation.
Zhang Y; Lees E
Mol Cell Biol; 2001 Aug; 21(15):5190-9. PubMed ID: 11438673
[TBL] [Abstract][Full Text] [Related]
17. Homeostatic control of mitotic arrest.
Varetti G; Guida C; Santaguida S; Chiroli E; Musacchio A
Mol Cell; 2011 Dec; 44(5):710-20. PubMed ID: 22152475
[TBL] [Abstract][Full Text] [Related]
18. N-Substituted pyrrolopyrimidines and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors.
Casalvieri KA; Matheson CJ; Warfield BM; Backos DS; Reigan P
Bioorg Med Chem; 2021 Jul; 41():116220. PubMed ID: 34034149
[TBL] [Abstract][Full Text] [Related]
19. Withaferin A modulates the Spindle assembly checkpoint by degradation of Mad2-Cdc20 complex in colorectal cancer cell lines.
Das T; Roy KS; Chakrabarti T; Mukhopadhyay S; Roychoudhury S
Biochem Pharmacol; 2014 Sep; 91(1):31-9. PubMed ID: 24995417
[TBL] [Abstract][Full Text] [Related]
20. Intermediates in the assembly of mitotic checkpoint complexes and their role in the regulation of the anaphase-promoting complex.
Kaisari S; Sitry-Shevah D; Miniowitz-Shemtov S; Hershko A
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):966-71. PubMed ID: 26755599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
